2024
DOI: 10.1016/j.ejso.2024.108019
|View full text |Cite
|
Sign up to set email alerts
|

Survival difference among adult and pediatric mediastinal yolk sac tumors cases: A meta-analysis of case reports

Anas Dabsha,
Ismail A.M.H. Elkharbotly,
Mohammad Yaghmour
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 19 publications
0
3
0
Order By: Relevance
“…Notably, in many cases, authors choose a similar approach as in our case, with neo-adjuvant chemotherapy (most often BEP-regimen), followed by complete surgical resection [ 11 , 26 29 ]. More recently a meta-analysis was published on mediastinal yolk sac tumors revealing a poor prognosis with a median time to survival of 23 months for adult patients, 3-year overall survival of 24.4%, and 5-year overall survival of 23% [ 30 ]. On multivariate analysis the main predictors for favorable outcome were: undergoing surgery, receiving chemotherapy, and a more anterior localization of the tumor [ 30 ].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Notably, in many cases, authors choose a similar approach as in our case, with neo-adjuvant chemotherapy (most often BEP-regimen), followed by complete surgical resection [ 11 , 26 29 ]. More recently a meta-analysis was published on mediastinal yolk sac tumors revealing a poor prognosis with a median time to survival of 23 months for adult patients, 3-year overall survival of 24.4%, and 5-year overall survival of 23% [ 30 ]. On multivariate analysis the main predictors for favorable outcome were: undergoing surgery, receiving chemotherapy, and a more anterior localization of the tumor [ 30 ].…”
Section: Discussionmentioning
confidence: 99%
“…More recently a meta-analysis was published on mediastinal yolk sac tumors revealing a poor prognosis with a median time to survival of 23 months for adult patients, 3-year overall survival of 24.4%, and 5-year overall survival of 23% [ 30 ]. On multivariate analysis the main predictors for favorable outcome were: undergoing surgery, receiving chemotherapy, and a more anterior localization of the tumor [ 30 ]. Furthermore, the authors claim that the most important cornerstones of the successful treatment of such malignancies are (1) early diagnosis (2) neoadjuvant chemotherapy and (3) surgical resection [ 30 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation